EASY BIO,Inc. (KOSDAQ:353810)
South Korea
· Delayed Price · Currency is KRW 6,330.00
+10.00 (0.16%)
At close: Dec 5, 2025
EASY BIO,Inc. Market Cap
EASY BIO,Inc. has a market cap or net worth of 209.41 billion as of December 5, 2025. Its market cap has increased by 71.11% in one year.
Market Cap
209.41B
Enterprise Value
346.22B
Revenue
465.24B
Ranking
n/a
PE Ratio
9.52
Stock Price
6,330.00
Market Cap Chart
Since June 5, 2020, EASY BIO,Inc.'s market cap has increased from 34.76B to 209.41B, an increase of 502.48%. That is a compound annual growth rate of 38.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 209.41B | 50.11% |
| Dec 30, 2024 | 139.50B | 12.89% |
| Dec 28, 2023 | 123.58B | -10.06% |
| Dec 29, 2022 | 137.40B | -14.99% |
| Dec 30, 2021 | 161.64B | -23.75% |
| Dec 18, 2020 | 211.99B | 509.90% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.96T |
| Celltrion | 40.11T |
| ALTEOGEN | 24.41T |
| ABL Bio | 10.51T |
| SK Biopharmaceuticals | 10.49T |
| Yuhan | 8,755.13B |
| LigaChem Biosciences | 6,753.15B |
| Peptron | 6,645.44B |